Nephrology News

16/11/2025

https://youtu.be/fMil5hhbFGE

Welcome to Podocyte Talk Episode 33!In this episode, we delve into three cutting-edge studies reshaping how we treat kidney diseases:🔹 Atacicept in IgA Neph...

02/09/2025

Welcome to Podocyte Talk! In Episode 31, we dive into three impactful studies that challenge nephrology norms and offer practical insights:🔹 Stopping Eculiz...

18/08/2025

In this episode of Podocyte Talk, we delve into three important studies shaping the management of advanced chronic kidney disease (CKD):

🔹 Exercise Before Dialysis

🔹 Cost-Effectiveness of Low-Protein Diets

🔹 Spironolactone in CKD

In this episode of Podocyte Talk, we delve into three important studies shaping the management of advanced chronic kidney disease (CKD):🔹 Exercise Before Di...

15/07/2025

In Episode 28 of Podocyte Talk, we discuss three clinically relevant studies advancing care in nephrology and transplant medicine:

Intradialytic Exercise Trial .

EVEREST Post-Hoc Analysis.

Transplant Infection Study (India).

In Episode 28 of Podocyte Talk, we discuss three clinically relevant studies advancing care in nephrology and transplant medicine:Intradialytic Exercise Tria...

01/07/2025

In this episode of Podocyte Talk, we explore three important studies shaping the future of kidney care:

GLP-1 receptor agonists in dialysis: Real-world data shows improved survival, weight loss, and higher transplant waitlisting rates among users.

Novel biomarkers in chronic kidney disease: Can biological markers predict kidney failure and mortality as well as traditional risk factors?

Foam sclerotherapy for kidney and liver cysts: A safe, effective procedure offering significant cyst volume reduction and improved quality of life.

In this episode of Podocyte Talk, we explore three important studies shaping the future of kidney care:GLP-1 receptor agonists in dialysis: Real-world data s...

16/06/2025

In Episode 26 of Podocyte Talk, we explore three timely studies:

1️⃣ A new trial on finerenone and empagliflozin shows that starting both together may offer superior protection against kidney disease progression in people with type 2 diabetes.

2️⃣ Hypoglycaemia is more common in older adults on dialysis, especially after morning sessions. What can we do to prevent it?

3️⃣ Tirzepatide, used for weight and diabetes management, also reduces proteinuria—even in patients without diabetes—without affecting filtration rate.

In Episode 26 of Podocyte Talk, we explore three timely studies:1️⃣ A new trial on finerenone and empagliflozin shows that starting both together may offer s...

01/06/2025

In Episode 25 of Podocyte Talk, we explore three high-impact studies that reflect how nephrology continues to intersect with cardiovascular risk, immunotherapy, and transplant outcomes:

🔹 Albuminuria and Atrial Fibrillation.
🔹 Long-Term Rituximab Outcomes in Membranous Nephropathy.
🔹 Pulmonary Hypertension in Kidney Transplantation.

In Episode 25 of Podocyte Talk, we explore three high-impact studies that reflect how nephrology continues to intersect with cardiovascular risk, immunothera...

15/05/2025

In Episode 24 of Podocyte Talk, we dive into three timely studies:
1️⃣ Real-world comparison of SGLT2 inhibitors and GLP-1 receptor agonists in preventing kidney failure
2️⃣ The impact of acute eGFR decline on finerenone’s cardiovascular and renal benefits
3️⃣ How high carbohydrate intake raises mortality risk in maintenance hemodialysis patients

In Episode 24 of Podocyte Talk, we dive into three timely studies:1️⃣ Real-world comparison of SGLT2 inhibitors and GLP-1 receptor agonists in preventing kid...

01/05/2025

In Episode 23 of Podocyte Talk, we dive into three important new studies: the use of finerenone in IgA nephropathy, the incidence and outcomes of acute kidney injury in very old patients, and the risk of urinary tract infections with SGLT2 inhibitors

In Episode 23 of Podocyte Talk, we dive into three important new studies: the use of finerenone in IgA nephropathy, the incidence and outcomes of acute kidne...

15/04/2025

Podocyte Talk is now twice monthly! Each episode includes 2 multiple-choice questions—answer in the comments and test your nephrology knowledge!

In this episode, we explore three impactful studies in nephrology:

1- Which phosphate binders lower mortality and slow vascular calcification?

2- How delayed immunosuppression harms kidney function in membranous nephropathy.

3- Why cancer risk may be higher in CKD patients—even before dialysis.

Podocyte Talk is now twice monthly! Each episode includes 2 multiple-choice questions—answer in the comments and test your nephrology knowledge!In this episo...

01/04/2025

This week on Podocyte Talk, we dive into three breakthrough studies in kidney medicine:
✅ SGLT2 inhibitors in patients with advanced CKD
✅ Anti-nephrin antibodies as relapse predictors in MCD & FSGS
✅ Sacubitril/valsartan improves dialysis access flow in heart failure

This week on Podocyte Talk, we dive into three breakthrough studies in kidney medicine:✅ SGLT2 inhibitors in patients with advanced CKD✅ Anti-nephrin antibod...

24/03/2025

In this episode of Podocyte Talk, we cover three important studies:

Blood pressure targets after kidney transplant
Whether to continue SGLT2 inhibitors during coronary angiography
Insights from continuous glucose monitoring in dialysis patients

Tune in for clinically relevant takeaways and practical guidance in nephrology care.

In this episode of Podocyte Talk, we cover three important studies:Blood pressure targets after kidney transplantWhether to continue SGLT2 inhibitors during ...